Signify Health Inc is a health information services business based in the US. Signify Health shares (SGFY) are listed on the NYSE and all prices are listed in US Dollars. Signify Health employs 2,100 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Guided Investing
Our top pick for
Experienced Investors
| Latest market close | $17.86 |
|---|---|
| 52-week range | $16.43 - $40.79 |
| 50-day moving average | $22.54 |
| 200-day moving average | $26.22 |
| Wall St. target price | $31.75 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.23 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $17.86 from 2021-10-14
| 1 week (2021-10-08) | -1.05% |
|---|---|
| 1 month (2021-09-15) | -22.68% |
| 3 months (2021-07-15) | -33.78% |
| 6 months (2021-04-15) | -33.83% |
| 1 year (2020-10-11) | N/A |
|---|---|
| 2 years (2019-10-11) | N/A |
| 3 years (2018-10-11) | N/A |
| 5 years (2016-10-11) | N/A |
Valuing Signify Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Signify Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Signify Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $126.2 million.
The EBITDA is a measure of a Signify Health's overall financial performance and is widely used to measure a its profitability.
To put Signify Health's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $741 million |
|---|---|
| Operating margin TTM | 8.11% |
| Gross profit TTM | $308 million |
| Return on assets TTM | 1.63% |
| Return on equity TTM | -1.57% |
| Profit margin | -5.09% |
| Book value | $6.33 |
| Market capitalisation | $3 billion |
TTM: trailing 12 months
There are currently 3.3 million Signify Health shares held short by investors – that's known as Signify Health's "short interest". This figure is 17.5% up from 2.8 million last month.
There are a few different ways that this level of interest in shorting Signify Health shares can be evaluated.
Signify Health's "short interest ratio" (SIR) is the quantity of Signify Health shares currently shorted divided by the average quantity of Signify Health shares traded daily (recently around 984270.74626866). Signify Health's SIR currently stands at 3.35. In other words for every 100,000 Signify Health shares traded daily on the market, roughly 3350 shares are currently held short.
To gain some more context, you can compare Signify Health's short interest ratio against those of similar companies.
However Signify Health's short interest can also be evaluated against the total number of Signify Health shares, or, against the total number of tradable Signify Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Signify Health's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Signify Health shares in existence, roughly 20 shares are currently held short) or 0.1844% of the tradable shares (for every 100,000 tradable Signify Health shares, roughly 184 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Signify Health.
Find out more about how you can short Signify Health stock.
We're not expecting Signify Health to pay a dividend over the next 12 months.
You may also wish to consider:
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates in two segments, Home & Community Services and Episodes of Care Services. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers primarily under the Medicare Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. Its customers include health plans, governments, employers, health systems, and physician groups. The company was founded in 2017 and is headquartered in Dallas, Texas with additional offices in Austin, New York, Norwalk, and Rapid City.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.